ABBV ▼ -1.2% - AbbVie Inc.
$ABBV - AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
30-SEP-2026 01:01 AM ET
Share this post
More filings for $ABBV
ABBV ▲ +1.3% - AbbVie Inc.Oct 19, 2026ABBV ▲ +1.3% - AbbVie Inc.Oct 17, 2026ABBV ▼ -2.4% - AbbVie Inc.Oct 13, 2026ABBV ▲ +1.5% - AbbVie Inc.Oct 11, 2026ABBV ▲ +0.6% - AbbVie Inc.Oct 7, 2026ABBV ▲ +0.6% - AbbVie Inc.Oct 5, 2026
View full $ABBV filing history →💬 Comments
Loading comments…
Leave a comment